BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Skin cancer AND FIP1L1, DKFZp586K0717, 81608, ENSG00000145216, Q6UN15
9 results:

  • 1. Detection of fip1l1-PDGFRA fusion gene-positive cells in the skin lesion of a patient with hypereosinophilic syndrome.
    Kitayama S; Makino T; Yoto A; Mori S; Furukawa F; Torai R; Mizawa M; Shimizu T
    Clin Exp Dermatol; 2023 Mar; 48(4):364-367. PubMed ID: 36763740
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Epidemiology, clinical picture and long-term outcomes of fip1l1-PDGFRA-positive myeloid neoplasm with eosinophilia: Data from 151 patients.
    Rohmer J; Couteau-Chardon A; Trichereau J; Panel K; Gesquiere C; Ben Abdelali R; Bidet A; Bladé JS; Cayuela JM; Cony-Makhoul P; Cottin V; Delabesse E; Ebbo M; Fain O; Flandrin P; Galicier L; Godon C; Grardel N; Guffroy A; Hamidou M; Hunault M; Lengline E; Lhomme F; Lhermitte L; Machelart I; Mauvieux L; Mohr C; Mozicconacci MJ; Naguib D; Nicolini FE; Rey J; Rousselot P; Tavitian S; Terriou L; Lefèvre G; Preudhomme C; Kahn JE; Groh M;
    Am J Hematol; 2020 Nov; 95(11):1314-1323. PubMed ID: 32720700
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Spitz Tumors With ROS1 Fusions: A Clinicopathological Study of 6 Cases, Including FISH for Chromosomal Copy Number Alterations and Mutation Analysis Using Next-Generation Sequencing.
    Donati M; Kastnerova L; Martinek P; Grossmann P; Sticová E; Hadravský L; Torday T; Kyclova J; Michal M; Kazakov DV
    Am J Dermatopathol; 2020 Feb; 42(2):92-102. PubMed ID: 31361613
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. CD30+ clonal T-cell lymphoid proliferation of the skin in a patient with hypereosinophilic syndrome.
    Kempf W; Kazakov DV; Szep Z; Vanecek T
    J Cutan Pathol; 2015 Feb; 42(2):130-5. PubMed ID: 25421540
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. [Incidence and causes of hypereosinophilia (corrected) in the patients of a university hospital].
    Kim DW; Shin MG; Yun HK; Kim SH; Shin JH; Suh SP; Ryang DW
    Korean J Lab Med; 2009 Jun; 29(3):185-93. PubMed ID: 19571614
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Imatinib: new indication. New indications, but not robust evidence.
    Prescrire Int; 2008 Jun; 17(95):91-4. PubMed ID: 18623899
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Platelet-derived growth factor receptor-alpha-associated hypereosinophilic syndrome and lymphomatoid papulosis.
    McPherson T; Cowen EW; McBurney E; Klion AD
    Br J Dermatol; 2006 Oct; 155(4):824-6. PubMed ID: 16965435
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Imatinib mesylate in the treatment of systemic mastocytosis: a phase II trial.
    Droogendijk HJ; Kluin-Nelemans HJ; van Doormaal JJ; Oranje AP; van de Loosdrecht AA; van Daele PL
    Cancer; 2006 Jul; 107(2):345-51. PubMed ID: 16779792
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. A comprehensive review of imatinib mesylate (Gleevec) for dermatological diseases.
    Scheinfeld N
    J Drugs Dermatol; 2006 Feb; 5(2):117-22. PubMed ID: 16485879
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.